278 related articles for article (PubMed ID: 33392515)
1. Revealing the impact of structural variants in multiple myeloma.
Rustad EH; Yellapantula VD; Glodzik D; Maclachlan KH; Diamond B; Boyle EM; Ashby C; Blaney P; Gundem G; Hultcrantz M; Leongamornlert D; Angelopoulos N; Agnelli L; Auclair D; Zhang Y; Dogan A; Bolli N; Papaemmanuil E; Anderson KC; Moreau P; Avet-Loiseau H; Munshi NC; Keats JJ; Campbell PJ; Morgan GJ; Landgren O; Maura F
Blood Cancer Discov; 2020 Nov; 1(3):258-273. PubMed ID: 33392515
[TBL] [Abstract][Full Text] [Related]
2. Structural variants shape the genomic landscape and clinical outcome of multiple myeloma.
Ashby C; Boyle EM; Bauer MA; Mikulasova A; Wardell CP; Williams L; Siegel A; Blaney P; Braunstein M; Kaminetsky D; Keats J; Maura F; Landgren O; Walker BA; Davies FE; Morgan GJ
Blood Cancer J; 2022 May; 12(5):85. PubMed ID: 35637217
[TBL] [Abstract][Full Text] [Related]
3. Chromothripsis as a pathogenic driver of multiple myeloma.
Maura F; Boyle EM; Rustad EH; Ashby C; Kaminetzky D; Bruno B; Braunstein M; Bauer M; Blaney P; Wang Y; Ghamlouch H; Williams L; Stoeckle J; Davies FE; Walker BA; Maclachlan K; Diamond B; Landgren O; Morgan GJ
Semin Cell Dev Biol; 2022 Mar; 123():115-123. PubMed ID: 33958284
[TBL] [Abstract][Full Text] [Related]
4. Genomic landscape and chronological reconstruction of driver events in multiple myeloma.
Maura F; Bolli N; Angelopoulos N; Dawson KJ; Leongamornlert D; Martincorena I; Mitchell TJ; Fullam A; Gonzalez S; Szalat R; Abascal F; Rodriguez-Martin B; Samur MK; Glodzik D; Roncador M; Fulciniti M; Tai YT; Minvielle S; Magrangeas F; Moreau P; Corradini P; Anderson KC; Tubio JMC; Wedge DC; Gerstung M; Avet-Loiseau H; Munshi N; Campbell PJ
Nat Commun; 2019 Aug; 10(1):3835. PubMed ID: 31444325
[TBL] [Abstract][Full Text] [Related]
5. Reconstructing the evolutionary history of multiple myeloma.
Maura F; Rustad EH; Boyle EM; Morgan GJ
Best Pract Res Clin Haematol; 2020 Mar; 33(1):101145. PubMed ID: 32139011
[TBL] [Abstract][Full Text] [Related]
6. Impact of Rare Structural Variant Events in Newly Diagnosed Multiple Myeloma.
Chojnacka M; Diamond B; Ziccheddu B; Rustad E; Maclachlan K; Papadimitriou M; Boyle EM; Blaney P; Usmani S; Morgan G; Landgren O; Maura F
Clin Cancer Res; 2024 Feb; 30(3):575-585. PubMed ID: 37939148
[TBL] [Abstract][Full Text] [Related]
7. Defining the diverse spectrum of inversions, complex structural variation, and chromothripsis in the morbid human genome.
Collins RL; Brand H; Redin CE; Hanscom C; Antolik C; Stone MR; Glessner JT; Mason T; Pregno G; Dorrani N; Mandrile G; Giachino D; Perrin D; Walsh C; Cipicchio M; Costello M; Stortchevoi A; An JY; Currall BB; Seabra CM; Ragavendran A; Margolin L; Martinez-Agosto JA; Lucente D; Levy B; Sanders SJ; Wapner RJ; Quintero-Rivera F; Kloosterman W; Talkowski ME
Genome Biol; 2017 Mar; 18(1):36. PubMed ID: 28260531
[TBL] [Abstract][Full Text] [Related]
8. Unravelling the tumour genome: The evolutionary and clinical impacts of structural variants in tumourigenesis.
Hamdan A; Ewing A
J Pathol; 2022 Jul; 257(4):479-493. PubMed ID: 35355264
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of chromothriptic complex chromosomal rearrangements in newly diagnosed multiple myeloma.
Kaur G; Gupta R; Mathur N; Rani L; Kumar L; Sharma A; Singh V; Gupta A; Sharma OD
Leuk Res; 2019 Jan; 76():58-64. PubMed ID: 30576858
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma.
Sharma N; Smadbeck JB; Abdallah N; Zepeda-Mendoza C; Binder M; Pearce KE; Asmann YW; Peterson JF; Ketterling RP; Greipp PT; Bergsagel PL; Rajkumar SV; Kumar SK; Baughn LB
Clin Cancer Res; 2021 Oct; 27(19):5430-5439. PubMed ID: 34233962
[TBL] [Abstract][Full Text] [Related]
11. Long-read sequencing of diagnosis and post-therapy medulloblastoma reveals complex rearrangement patterns and epigenetic signatures.
Rausch T; Snajder R; Leger A; Simovic M; Giurgiu M; Villacorta L; Henssen AG; Fröhling S; Stegle O; Birney E; Bonder MJ; Ernst A; Korbel JO
Cell Genom; 2023 Apr; 3(4):100281. PubMed ID: 37082141
[TBL] [Abstract][Full Text] [Related]
12. Impact of rare structural variant events in newly diagnosed multiple myeloma.
Chojnacka M; Diamond B; Ziccheddu B; Rustad E; Maclachlan K; Papadimitriou M; Boyle EM; Blaney P; Usmani S; Morgan G; Landgren O; Maura F
bioRxiv; 2023 Jan; ():. PubMed ID: 36711679
[TBL] [Abstract][Full Text] [Related]
13. Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities.
Oben B; Froyen G; Maclachlan KH; Leongamornlert D; Abascal F; Zheng-Lin B; Yellapantula V; Derkach A; Geerdens E; Diamond BT; Arijs I; Maes B; Vanhees K; Hultcrantz M; Manasanch EE; Kazandjian D; Lesokhin A; Dogan A; Zhang Y; Mikulasova A; Walker B; Morgan G; Campbell PJ; Landgren O; Rummens JL; Bolli N; Maura F
Nat Commun; 2021 Mar; 12(1):1861. PubMed ID: 33767199
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.
Cortés-Ciriano I; Lee JJ; Xi R; Jain D; Jung YL; Yang L; Gordenin D; Klimczak LJ; Zhang CZ; Pellman DS; ; Park PJ;
Nat Genet; 2020 Mar; 52(3):331-341. PubMed ID: 32025003
[TBL] [Abstract][Full Text] [Related]
15. Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma.
Maclachlan KH; Rustad EH; Derkach A; Zheng-Lin B; Yellapantula V; Diamond B; Hultcrantz M; Ziccheddu B; Boyle EM; Blaney P; Bolli N; Zhang Y; Dogan A; Lesokhin AM; Morgan GJ; Landgren O; Maura F
Nat Commun; 2021 Aug; 12(1):5172. PubMed ID: 34453055
[TBL] [Abstract][Full Text] [Related]
16. Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms.
Hoang PH; Dobbins SE; Cornish AJ; Chubb D; Law PJ; Kaiser M; Houlston RS
Leukemia; 2018 Nov; 32(11):2459-2470. PubMed ID: 29654271
[TBL] [Abstract][Full Text] [Related]
17. Whole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma.
Cheng C; Zhou Y; Li H; Xiong T; Li S; Bi Y; Kong P; Wang F; Cui H; Li Y; Fang X; Yan T; Li Y; Wang J; Yang B; Zhang L; Jia Z; Song B; Hu X; Yang J; Qiu H; Zhang G; Liu J; Xu E; Shi R; Zhang Y; Liu H; He C; Zhao Z; Qian Y; Rong R; Han Z; Zhang Y; Luo W; Wang J; Peng S; Yang X; Li X; Li L; Fang H; Liu X; Ma L; Chen Y; Guo S; Chen X; Xi Y; Li G; Liang J; Yang X; Guo J; Jia J; Li Q; Cheng X; Zhan Q; Cui Y
Am J Hum Genet; 2016 Feb; 98(2):256-74. PubMed ID: 26833333
[TBL] [Abstract][Full Text] [Related]
18. Chromothripsis detection with multiple myeloma patients based on deep graph learning.
Yu J; Chen N; Zheng Z; Gao M; Liang N; Wong KC
Bioinformatics; 2023 Jul; 39(7):. PubMed ID: 37399092
[TBL] [Abstract][Full Text] [Related]
19. Linked-read whole-genome sequencing resolves common and private structural variants in multiple myeloma.
Peña-Pérez L; Frengen N; Hauenstein J; Gran C; Gustafsson C; Eisfeldt J; Kierczak M; Taborsak-Lines F; Olsen RA; Wallblom A; Krstic A; Ewels P; Lindstrand A; Månsson R
Blood Adv; 2022 Sep; 6(17):5009-5023. PubMed ID: 35675515
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma.
Walker BA; Mavrommatis K; Wardell CP; Ashby TC; Bauer M; Davies FE; Rosenthal A; Wang H; Qu P; Hoering A; Samur M; Towfic F; Ortiz M; Flynt E; Yu Z; Yang Z; Rozelle D; Obenauer J; Trotter M; Auclair D; Keats J; Bolli N; Fulciniti M; Szalat R; Moreau P; Durie B; Stewart AK; Goldschmidt H; Raab MS; Einsele H; Sonneveld P; San Miguel J; Lonial S; Jackson GH; Anderson KC; Avet-Loiseau H; Munshi N; Thakurta A; Morgan GJ
Blood; 2018 Aug; 132(6):587-597. PubMed ID: 29884741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
